Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Persistently high quality of life conferred by coexisting congenital deficiency of terminal complement C9 in a paroxysmal nocturnal hemoglobinuria patient

Nobuyoshi Hanaoka, Yoshiko Murakami, Masahide Nagata, Shoichi Nagakura, Yuji Yonemura, Takashi Sonoki, Taroh Kinoshita, Hideki Nakakuma

Blood (2012) 119 (16): 3866–3868.

https://doi.org/10.1182/blood-2012-02-408161

Published: 2012

Journal Articles

Risk Factors Associated with VOD with RIC and MAC Hematopoietic Stem Cell Transplant and the Early Estimation of VOD

Shoichi Nagakura, Tetsuyuki Kiyokawa, Michihiro Hidaka, Takahiro Yano, MD, Kazutaka Sunami, MD, PhD, Seiichi Okamura, Naokuni Uike, Motohiro Hamaguchi, Takahiro Matsui, Keizo Horibe, MD, Kensaku Sato, Toshiro Kawakita, Fumio Kawano

Blood (2008) 112 (11): 4315.

https://doi.org/10.1182/blood.V112.11.4315.4315

Published: 2008

Journal Articles

Prognostic Factors Associated with Outcomes of RIC and MAC Hematopoietic Stem Cell Transplantation: An Indication for the Selection of Conditioning

Tetsuyuki Kiyokawa, Shoichi Nagakura, Michihiro Hidaka, Takahiro Yano, MD, Kazutaka Sunami, MD, PhD, Seiichi Okamura, Naokuni Uike, Motohiro Hamaguchi, Takahiro Matsui, Keizo Horibe, MD, Kensaku Sato, Toshiro Kawakita, Fumio Kawano

Blood (2008) 112 (11): 4402.

https://doi.org/10.1182/blood.V112.11.4402.4402

Published: 2008

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation as Consolidation Therapy for Adult T Cell Leukemia/Lymphoma Patients: A Single-Center Experience in 35 Patients.

Shigeki Takemoto, MD, Michihiro Hidaka, MD, Shoichi Nagakura, MD, Tatsunori Sakai, MD, Takahiro Matsui, MD, Toshiro Kawakita, MD, Yoshiko Inoue, MD, Atsuko Tsukamoto, MD, Tetsuyuki Kiyokawa, MD, Fumio Kawano, MD

Blood (2007) 110 (11): 5037.

https://doi.org/10.1182/blood.V110.11.5037.5037

Published: 2007

Journal Articles

Number of Prior Chemotherapy Regimens: Important Prognositic Factor of All-Cause Mortality after Allogeneic Hematopoietic Cell Transplantation.

Tetsuyuki Kiyokawa, MD, Shoichi Nagakura, MD, Michihiro Hidaka, MD, Naokuni Uike, MD, Motohiro Hamaguchi, MD, Keizo Horibe, MD, Kensaku Sato, Humio Kawano, MD

Blood (2007) 110 (11): 1104.

https://doi.org/10.1182/blood.V110.11.1104.1104

Published: 2007

Journal Articles

NKG2D-Mediated Marrow Injury in Paroxysmal Nocturnal Hemoglobinuria and Its Related Disorders.

Nobuyoshi Hanaoka, MD, PhD, Tatsuya Kawaguchi, MD, PhD, Kentaro Horikawa, MD, PhD, Shoichi Nagakura, MD, PhD, Sonoko Ishihara, MD, PhD, Yasuchika Tsuzuki, MD, Yuji Yonemura, MD, PhD, Hideki Nakakuma, MD, PhD

Blood (2007) 110 (11): 3674.

https://doi.org/10.1182/blood.V110.11.3674.3674

Published: 2007

Journal Articles

ULBP and MICA/B as Novel Indicators for Both Diagnosis of Immune-Mediated Marrow Injury and Favorable Response to Immunosuppressive Therapy in Bone Marrow Failure Syndromes.

Nobuyoshi Hanaoka, MD, PhD, Tatsuya Kawaguchi, MD, PhD, Kentaro Horikawa, MD, PhD, Shoichi Nagakura, MD, PhD, Yasuchika Tsuzuki, MD, Yuji Yonemura, MD, PhD, Hideki Nakakuma, MD, PhD

Blood (2006) 108 (11): 990.

https://doi.org/10.1182/blood.V108.11.990.990

Published: 2006

Journal Articles

Immunoselection by natural killer cells of PIGA mutant cells missing stress-inducible ULBP

Nobuyoshi Hanaoka, Tatsuya Kawaguchi, Kentaro Horikawa, Shoichi Nagakura, Hiroaki Mitsuya, Hideki Nakakuma

Blood (2006) 107 (3): 1184–1191.

https://doi.org/10.1182/blood-2005-03-1337

Published: 2006

Journal Articles

Appearance of Stress-Inducible Membrane Proteins ULBP on Blood Cells of Patients with PNH, Aplastic Anemia, and MDS: Possible Implication of ULBP in Immune-Mediated Marrow Injury.

Nobuyoshi Hanaoka, MD, Kentaro Horikawa, MD, PhD, Yasuchika Tsuzuki, MD, Shoichi Nagakura, MD, PhD, Sonoko Ishihara, MD, PhD, Hiroaki Mitsuya, MD, PhD, Hideki Nakakuma, MD, PhD, Tatsuya Kawaguchi, MD, PhD

Blood (2005) 106 (11): 1041.

https://doi.org/10.1182/blood.V106.11.1041.1041

Published: 2005

Journal Articles

Decrease in Sensitivity of PIG-A -Mutant Cells to Natural Killer Cells Conferred by Missing of Stress-Inducible Membrane Proteins ULBPs.

Nobuyoshi Hanaoka, MD, Tatsuya Kawaguchi, MD, PhD, Kentaro Horikawa, MD, PhD, Shoichi Nagakura, MD, PhD, Sonoko Ishihara, MD, PhD, Hiroaki Mitsuya, MD, PhD, Hideki Nakakuma, MD, PhD

Blood (2004) 104 (11): 2829.

https://doi.org/10.1182/blood.V104.11.2829.2829

Published: 2004

Journal Articles

Decreased susceptibility of leukemic cells with PIG-A mutation to natural killer cells in vitro

Shoichi Nagakura, Sonoko Ishihara, Daniel E. Dunn, Jun-ichi Nishimura, Tatsuya Kawaguchi, Kentaro Horikawa, Michihiro Hidaka, Tadashi Kagimoto, Nozomu Eto, Hiroaki Mitsuya, Taroh Kinoshita, Neal S. Young, Hideki Nakakuma

Blood (2002) 100 (3): 1031–1037.

https://doi.org/10.1182/blood.V100.3.1031

Published: 2002

Journal Articles

Frequent detection of T cells with mutations of the hypoxanthine-guanine phosphoribosyl transferase gene in patients with paroxysmal nocturnal hemoglobinuria

Kentaro Horikawa, Tatsuya Kawaguchi, Sonoko Ishihara, Shoichi Nagakura, Michihiro Hidaka, Tadashi Kagimoto, Hiroaki Mitsuya, Hideki Nakakuma

Blood (2002) 99 (1): 24–29.

https://doi.org/10.1182/blood.V99.1.24

Published: 2002

Journal Articles

Apoptosis Resistance of Blood Cells From Patients With Paroxysmal Nocturnal Hemoglobinuria, Aplastic Anemia, and Myelodysplastic Syndrome

Kentaro Horikawa, Hideki Nakakuma, Tatsuya Kawaguchi, Norihiro Iwamoto, Shoichi Nagakura, Tadashi Kagimoto, Kiyoshi Takatsuki

Blood (1997) 90 (7): 2716–2722.

https://doi.org/10.1182/blood.V90.7.2716

Published: 1997

NARROW

Persistently high quality of life conferred by coexisting congenital deficiency of terminal complement C9 in a paroxysmal nocturnal hemoglobinuria patient

Risk Factors Associated with VOD with RIC and MAC Hematopoietic Stem Cell Transplant and the Early Estimation of VOD

Prognostic Factors Associated with Outcomes of RIC and MAC Hematopoietic Stem Cell Transplantation: An Indication for the Selection of Conditioning

Allogeneic Hematopoietic Stem Cell Transplantation as Consolidation Therapy for Adult T Cell Leukemia/Lymphoma Patients: A Single-Center Experience in 35 Patients.

Number of Prior Chemotherapy Regimens: Important Prognositic Factor of All-Cause Mortality after Allogeneic Hematopoietic Cell Transplantation.

NKG2D-Mediated Marrow Injury in Paroxysmal Nocturnal Hemoglobinuria and Its Related Disorders.

ULBP and MICA/B as Novel Indicators for Both Diagnosis of Immune-Mediated Marrow Injury and Favorable Response to Immunosuppressive Therapy in Bone Marrow Failure Syndromes.

Immunoselection by natural killer cells of PIGA mutant cells missing stress-inducible ULBP

Appearance of Stress-Inducible Membrane Proteins ULBP on Blood Cells of Patients with PNH, Aplastic Anemia, and MDS: Possible Implication of ULBP in Immune-Mediated Marrow Injury.

Decrease in Sensitivity of PIG-A -Mutant Cells to Natural Killer Cells Conferred by Missing of Stress-Inducible Membrane Proteins ULBPs.

Decreased susceptibility of leukemic cells with PIG-A mutation to natural killer cells in vitro

Frequent detection of T cells with mutations of the hypoxanthine-guanine phosphoribosyl transferase gene in patients with paroxysmal nocturnal hemoglobinuria

Apoptosis Resistance of Blood Cells From Patients With Paroxysmal Nocturnal Hemoglobinuria, Aplastic Anemia, and Myelodysplastic Syndrome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only